Cambridge Investment Research Advisors Inc. reduced its stake in shares of MSCI Inc. (NYSE:MSCI) by 19.3% during the 1st quarter, according to its most recent filing with the SEC. The firm owned 1,615 shares of the technology company’s stock after selling 387 shares during the period. Cambridge Investment Research Advisors Inc.’s holdings in MSCI were worth $677,000 at the end of the most recent quarter.
Other institutional investors and hedge funds also recently made changes to their positions in the company. Motco acquired a new stake in shares of MSCI during the 4th quarter valued at about $25,000. Semmax Financial Advisors Inc. acquired a new stake in shares of MSCI during the 1st quarter valued at about $25,000. Wealthcare Advisory Partners LLC acquired a new stake in shares of MSCI during the 1st quarter valued at about $28,000. Vantage Consulting Group Inc acquired a new stake in shares of MSCI during the 4th quarter valued at about $33,000. Finally, Parkside Financial Bank & Trust grew its position in shares of MSCI by 123.5% during the 4th quarter. Parkside Financial Bank & Trust now owns 76 shares of the technology company’s stock valued at $34,000 after acquiring an additional 42 shares during the period. 89.92% of the stock is currently owned by institutional investors.
MSCI has been the topic of a number of analyst reports. Zacks Investment Research cut MSCI from a “buy” rating to a “hold” rating and set a $511.00 target price on the stock. in a research report on Tuesday, May 4th. Oppenheimer raised their price target on shares of MSCI from $493.00 to $533.00 and gave the company an “outperform” rating in a research note on Wednesday, April 28th. Morgan Stanley raised their price target on shares of MSCI from $448.00 to $473.00 and gave the company an “equal weight” rating in a research note on Wednesday, April 28th. Finally, Deutsche Bank Aktiengesellschaft raised their price target on shares of MSCI from $475.00 to $525.00 and gave the company a “buy” rating in a research note on Wednesday, April 28th. Three research analysts have rated the stock with a hold rating and five have assigned a buy rating to the stock. MSCI currently has a consensus rating of “Buy” and a consensus price target of $499.43.
MSCI (NYSE:MSCI) last released its earnings results on Tuesday, April 27th. The technology company reported $2.46 earnings per share for the quarter, topping the Zacks’ consensus estimate of $2.25 by $0.21. MSCI had a net margin of 37.02% and a negative return on equity of 173.63%. The business had revenue of $478.40 million for the quarter, compared to analyst estimates of $470.34 million. During the same period last year, the company posted $1.90 EPS. The business’s revenue was up 14.8% on a year-over-year basis. Equities research analysts expect that MSCI Inc. will post 9.6 earnings per share for the current fiscal year.
The firm also recently announced a quarterly dividend, which was paid on Friday, May 28th. Shareholders of record on Friday, May 14th were paid a $0.78 dividend. This represents a $3.12 dividend on an annualized basis and a yield of 0.65%. The ex-dividend date of this dividend was Thursday, May 13th. MSCI’s dividend payout ratio (DPR) is 39.85%.
In other MSCI news, COO Cd Baer Pettit sold 2,500 shares of the firm’s stock in a transaction that occurred on Tuesday, May 4th. The shares were sold at an average price of $484.11, for a total value of $1,210,275.00. Following the transaction, the chief operating officer now directly owns 259,380 shares of the company’s stock, valued at approximately $125,568,451.80. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at the SEC website. Company insiders own 2.93% of the company’s stock.
MSCI Company Profile
MSCI Inc, together with its subsidiaries, provides investment decision support tools for the clients to manage their investment processes worldwide. The company operates through Index, Analytics, and All Other segments. The Index segment primarily provides indexes for use in various areas of the investment process, including indexed product creation, such as ETFs, mutual funds, annuities, futures, options, structured products, over-the-counter derivatives; performance benchmarking; portfolio construction and rebalancing; and asset allocation, as well as licenses GICS and GICS Direct.
Featured Article: How to calculate compound interest
Want to see what other hedge funds are holding MSCI? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for MSCI Inc. (NYSE:MSCI).
Receive News & Ratings for MSCI Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for MSCI and related companies with MarketBeat.com's FREE daily email newsletter.